Navigation Links
Common treatment for men's pelvic pain proves ineffective, Queen's-led study shows
Date:12/18/2008

Kingston, ON A commonly-prescribed drug for men suffering from a painful pelvic condition failed to significantly reduce patients' symptoms in an international study led by Queen's University professor and urologist at Kingston General Hospital, Curtis Nickel.

The drug, called Alfuzosin, is regularly prescribed by more than half of family doctors to treat chronic prostititis/chronic pelvic pain syndrome. This affliction is estimated to affect from six to 12 per cent of the population.

Sponsored by the U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health, the study is published today in the prestigious New England Journal of Medicine.

"The results of our study will inform not only future clinical trials of alpha-blockers, but also other potential therapies," says Dr. Nickel, who is Canada Research Chair in Urologic Pain and Inflammation.

"Although the evidence for using alpha-blockers to treat new cases of chronic prostatitis/chronic pelvic pain syndrome is weak, some physicians have advocated use of this class of drug in men with this condition," he adds. "Our findings do not support this recommendation and should prompt reconsideration of use of an alpha-blocker as the first drug of choice for these patients."

Prostatitis is a common and costly medical condition, with chronic prostatitis/chronic pelvic pain syndrome the most frequent type seen by physicians. Men with this condition experience pain in the genital and urinary tract area and also report lower urinary tract symptoms and sexual problems that negatively affect their quality of life.

In the Queen's-led study, 233 men diagnosed with chronic prostatitis/chronic pelvic pain syndrome were randomly assigned to either alfuzosin or an identical-looking placebo. None of the men had received prior treatment with a beta-blocker.

Over the 12-week trial, participants wer
'/>"/>

Contact: Nancy Dorrance
nancy.dorrance@queensu.ca
Queen's University
Source:Eurekalert  

0

GOOD

Page: 1 2

Related medicine news :

1. Common treatment for chronic prostatitis fails to reduce symptoms
2. Common infant virus may trigger type 1 diabetes
3. Migraines: Help for a common problem in children and teenagers
4. Latino Psychologist Appointed to Mental Health Post in Commonwealth
5. PA Department of Health Revokes Hospital License for Commonwealth Medical Center in Beaver County
6. Two common diabetes drugs double the risk of fractures in women
7. Brain Boosting Drugs vs. Walking: Treadmill Desk Manufacturer Promotes Common Sense
8. Encision Announces Quoting of Common Stock on the OTC Bulletin Board
9. Self-Dosing Pain Medication Errors Too Common: Study
10. A book of common prayers
11. Study finds treatment fails to improve common form of heart failure

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Common treatment for men's pelvic pain proves ineffective, Queen's-led study shows
Common treatment for men's pelvic pain proves ineffective, Queen's-led study shows
(Date:12/1/2009)... , LOS ANGELES, Dec. 1 A dec...ational Labor Relations Board (NLRB) has put at ri... pensions of Kaiser Permanente RNs, social workers..."We have worked for years to achieve standards at ...de the professional care our patients need," said ...
(Date:12/1/2009)...centa accreta is increasingly common but more easi...Dec. 1 (HealthDay News) -- A magnetic resonance i...e-threatening pregnancy complication called placen... occurs when the placenta surrounding a fetus atta...ry, the placenta can pull out parts of the uterine...
(Date:12/1/2009)...OUSTON - Using routine computed tomography (CT) im...lorectal liver metastasis after bevacizumab and ch... to research from The University of Texas M. D. An...ed in the Dec. 2 issue of JAMA . , When combine...vacizumab, also known as Avastin, is associated wi...
(Date:12/1/2009)... , NEW ORLEANS, Dec. 1 /PRNewswire-USNe...) will host its annual High School Student Symposi...er 3, at 8:00 a.m. CST. The symposium, which encou...iences, and medical research, is held in conjuncti...ar, students will have the opportunity to explore ...
(Date:12/1/2009)... , NEW ORLEANS, Dec. 1 /PRNewswire-USNews... the world,s largest professional association of b...es at the 51st ASH Annual Meeting from December 5-... in New Orleans, LA. The meeting will showcase the...s. ,, "It is my pleasure to host ASH,s 51st an...
Breaking Medicine News(10 mins):Health News:Labor Board Decision Puts Kaiser Workers' Pay, Healthcare, Pensions in Jeopardy 2Health News:Serious Pregnancy Complication Detected With MRI 2Health News:CT imaging taken post avastin may predict survival in patients with metastatic colorectal cancer 2Health News:CT imaging taken post avastin may predict survival in patients with metastatic colorectal cancer 3Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 3Health News:51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care 2Health News:51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care 3
... with prostate cancer who have their prostate remo...e effect after surgery, but urinary dysfunction tr...f Florida researcher. Whats more, many arent emoti...re practitioners to educate their patients about t...
... CALL DATE: Wednesday, Feb. 27, 2008 ... HOST: Dr. Candace Kendle, Chairman and ...one conference call and,simultaneous webcast Feb. ...follow., (Logo: http://www.newscom.com/cgi-bin/p...
...to silence union activist, CHICAGO, Jan. 30 Regi... has issued an unfair labor practice complaint,aga... to silence a union,supporter at West Suburban Med...r speak to his coworkers in the Food Service,depar...
...in Relief Alternative To Prescription and ...GELES, Jan. 30 One in ten Americans report,suffer...nd debilitating,arthritis. Most often, pain suffer... to educate consumers about pain,relieving alterna...
...30 Expanding the,pipeline of HIV prevention tools... Microbicides (IPM) today announced that Pfizer In...license to maraviroc, its,newly-approved HIV treat...ntiretroviral drugs known as CCR5 blockers, which,...
...30, 2007 Aggression, testosterone and nepotism do...ut the support of a good female can, according to ...rican species of fish. , The study, published tod...ics. , We found that changes in social status w...
Other Medicine News:Health News:Urinary dysfunction troubles men who undergo prostate removal 2Health News:Urinary dysfunction troubles men who undergo prostate removal 3Health News:Kendle Invites You to Attend Its Fourth Quarter and Year End 2007 Earnings Conference Call and Webcast 2Health News:Labor Board Issues Complaint Against Resurrection Health Care 2Health News:Photos: Niavin Corporation Offers Pain Sufferers a New Way to Address Pain 2Health News:IPM Reaches Landmark Agreement with Pfizer to Develop FDA-Approved Antiretroviral Drug as Vaginal Microbicide 2Health News:IPM Reaches Landmark Agreement with Pfizer to Develop FDA-Approved Antiretroviral Drug as Vaginal Microbicide 3Health News:Females decide whether ambitious males float or flounder 2
(Date:12/1/2009)...nt radiation reduction in cardiac CT scans ,, C...s Earls, a radiologist from Fairfax Radiological C...nt the findings of a study that shows a 90 percent...ts received from CT scans compared to scans perfor...the study to the annual meeting of the Radiologica...
(Date:12/1/2009)....J., Dec. 1 Former New J... delighted when his radiotherapy treatment session...ach day to less than five. Midway through his cou...Urology Cancer Center acquired the region,s firs...rian Medical Systems (NYSE: VAR ), making it pos...
(Date:12/1/2009)...c. 1 Cumberland Pharmace... an independently conducted study of Acetadote ( a...cysteine, as a cost-saving treatment for acetamino...4 of the peer-reviewed Journal of Medical Economi...s that Acetadote is a less costly treatment regime...
Breaking Medicine Technology:Radiation Reduction in Heart CT Scans Reported in Study 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 2Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 3Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 4Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 5Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 6Frutarom Launches New Global Branding 5437 1Frutarom Launches New Global Branding 5437 2Frutarom Launches New Global Branding 5437 3Sangamo Announces Closing of Common Stock Offering 5433 1Sangamo Announces Closing of Common Stock Offering 5433 2Sangamo Announces Closing of Common Stock Offering 5433 3Bioluminescence imaging used for eye cancer detection 59379 1Bioluminescence imaging used for eye cancer detection 59379 2
...h Kogenate FS Reduces the,Risk of Joint Damage and...Joint Damage, BERKELEY, Calif., Oct. 10 Bayer He...d Drug Administration (FDA) has,approved routine p...or,(Recombinant) to reduce the frequency of bleedi...ts aged 0-16 years with severe hemophilia A with n...
...orporation (NYSE: BSX ) today announced the sched...cements at the Cardiovascular Research Foundation,...lar Therapeutics (TCT),scientific symposium, which...Boston Scientific will be announcing a wide range ...s2(TM) and second-generation TAXUS(R),Liberte(R) P...
Other Medicine Technology:FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6
Akbarnia PDR
Spinal Instruments
Autologous Growth Factors
Leica D2D V3
Medicine Products: